Increased digitalis-like immunoreactive substances in neonatal plasma measured using fluorescence polarization immunoassay

Journal of Clinical Pharmacy and Therapeutics

Volumn 29, Issue 6, 2004, Pages 565-571

  Ijiri, Y ^a   Hayahi, T ^b   Ogihara, T ^b   Ohi, K ^a   Suzuki, K ^a   Tamai, H ^b   Kitaura, Y ^b   Takenaka, H ^a   Tanaka, Kazuhiko ^b  

^a OSAKA MEDICAL COLLEGE HOSPITAL   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Bilirubin; Digitalis like immunoreactive substances; Fluorescence polarization immunoassay; Microparticle enzyme immunoassay; Neonate

Indexed keywords

BILIRUBIN; DIGITALIS LIKE FACTOR; DIGOXIN;

ARTICLE; BILIRUBIN BLOOD LEVEL; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIGOXIN BLOOD LEVEL; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; GESTATIONAL AGE; HEART DISEASE; HUMAN; HUMAN TISSUE; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; NEWBORN; NEWBORN JAUNDICE; PHOTOTHERAPY; STATISTICAL ANALYSIS; VOLUNTEER;

BILIRUBIN; CARDENOLIDES; CARDIOVASCULAR AGENTS; CHILD, PRESCHOOL; DIGOXIN; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HEART DISEASES; HUMANS; INFANT; INFANT, NEWBORN; JAUNDICE; MALE; PHOTOTHERAPY; REFERENCE VALUES; SAPONINS;

EID: 10844285304     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2004.00609.x     Document Type: Article

References (25)

1. Gruber KA, Whitaker JM, Buckalew VM Jr (1980) Endogenous digitalis-like substance in plasma of volume-expanded dogs. Nature, 287, 743-745.
2. Seccombe DW, Pudek MR, Nowaczynski W et al. (1989) Digoxin-like immunoreactivity, displacement of ouabain and inhibition of Na+/K+ATPase by four steroids known to be increased in essential hypertension. Clinical Biochemistry, 22, 17-21.
3. Yamada K, Goto A, Nagoshi H et al. (1994) Role of brain ouabainlike compound in central nervous system-mediated natriuresis in rat. Hypertension, 23, 1027-1031.
4. Bagrov AY, Fedorova OV, Maslova MN et al. (1991) Endogenous plasma Na, K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction. Cardiovascular Research, 25, 371-377.
5. Gottlieb SS, Rogowski AC, Weinberg M et al. (1992) Elevated concentrations of endogeneous ouabain in patients with congestive heart failure. Circulation, 86, 420-125.
6. Ijiri Y, Hayashi T, Shimomura H et al. (1999) Digoxin-like immunoreactive substances in plasma of patients with hypertrophic cardiomyopathy. The Journal of Osaka Medical College, 58, 67-74.
7. Hayashi T, Ijiri Y, Toko H et al. (2000) Increased digitalis-like immunoreactive substances in patients with hypertrophie cardiomyopathy. European Heart Journal, 21, 296-305.
8. Graves SW, Brown B, Valdes R Jr (1983) An endogenous digoxin-like substance in patients with renal impairment. Annals of Internal Medicine, 99, 604-608.
9. Kulaots IA, Pudek MR, Seccombe DW (1987) Endogenous digoxin-like immunoreactive substances eliminated from serum samples from patients with liver disease by the EMIT column digoxin assay. Clinical Chemistry, 33, 1490-1491.
10. Graves SW, Valdes R Jr, Brown BA et al. (1984) Endogenous digoxin-like immunoreactive substance in human pregnancies. Journal of Clinical Endocrinology and Metabolism, 58, 748-751.
11. Seccombe DW, Pudek MR, Humphries KH, Matthewson B (1989) A study into the nature and organ source of digoxin-like immunoreactive substance(s) in the perinatal period. Biology of the Neonate, 56, 136-146.
12. Morris RP, David WS, Beryl EJ, Michael FW (1983) Seven different digoxin immunoassay kits compared with respect to interference by a digoxin-like immunoreactive substance in serum from premature and full-term infants. Clinical Chemistry, 29, 1972-1974
13. Chicella M, Branim B, Lee KR et al. (1998) Comparison of microparticle enzyme and fluorescence polarization immunoassays in pediatric patients not receiving digoxin. Therapeutic Drug Monitoring, 20, 347-351.
14. Delva P, Devynck MA, Degan M et al. (1991) Plasma levels of an endogenous Na+-K+-pump inhibitor in relation to hemodynamic data in cardiopathic patients. Clinical Science, 81, 23-29.
15. Goto A, Yamada K, Yagi N et al. (1992) Physiology and pharmacology of endogeneous digitalis-like factors. Pharmacological Reviews, 44, 377-399.
16. Ijiri Y, Hayashi T, Kamegai H et al. (2003) Digitalis-like immunoreactive substances in maternal and umbilical-cord plasma; a comparative sensitivity study of fluorescence polarization immunoassay and microparticle enzyme immunoassay. Therapeutic Drug Monitoring 25, 234-239.
17. Gervais A, Nanji AA, Greenway DC et al. (1987) Digoxin-like immunoreactive substance (DLIS) in liver disease: comparison of clinical and laboratory parameters in patients with and without DLIS. Drug Intelligence and Clinical Pharmacy, 21, 450-452.
18. Rubaltelli F, Donzelli F, Largajolli G (1975) Effect of phototherapy on hepatic excretory function in newborns as measured by bromsulphalein clearance. Biology of the Neonate, 26, 333-336.
19. Gromisch DS, Lopez R, Cole HS, Coopermam JM (1977) Light (phototherapy) induced riboflavin deficiency in neonate. Journal of Pediatrics, 90, 118-122.
20. Jolley ME, Stroupe SD, Schwenzer KS et al. (1981) Fluorescence polarization immunoassay III. an automated system. Clinical Chemistry, 27, 1575-1579.
21. Popelka SR, Miller DM, Holen JT et al. (1981) Fluorescence polarization immunoassay II. Analyzer for the rapid and precise measurement of fluorescence polarization using disposable cuvettes. Clinical Chemistry, 27, 1198-1201.
22. Shaffar M, Stroupe S (1983) A general method for performing routine clinical chemistry on the Abbott TDX analyzer. Clinical Chemistry, 129, 1251 (abstract).
23. Fiore M, Mitchell J, Doan T et al. (1988) The abbott IMX automated bench top immunochemistry analyzer system. Clinical Chemistry, 34, 1726-1732.
24. Azzazy HM, Duh SH, Maturen A et al. (1997) Multicenter study of Abbott AxSYM digoxin II assay and comparison with 6 methods for susceptibility to digoxin-like immunoreactive factors. Clinical Chemistry, 43, 1635-1649.
25. Kawade N, Onishi S (1981) The prenatal and postnatal development in UDP glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in the human liver. Biochemical Journal, 196, 257-260.